Oxford University’s RECOVERY clinical trial has found that low-dose dexamethasone increases the chance of survival in patients with COVID-19 who require respiratory support. In the study, the drug ...
Weekly demand in the U.S. is up more than 600%. Last week, a study in the U.K. found that dexamethasone, a common steroid, increased survival in severely ill COVID-19 patients who needed help ...
Incidence of infections in clinical trials of treatments for relapsed/refractory multiple myeloma: Systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
Corticosteroids are known to diminish immune response ability, which is generally used in routine premedication for chemotherapy. The intersecting of timeframe between the corticosteroid's duration of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback